TONIX PHARMACEUTICALS ANNOUNCES LICENSING TNX-4900, A SELECTIVE SIGMA-1 RECEPTOR ANTAGONIST FOR CHRONIC NEUROPATHIC PAIN FROM RUTGERS UNIVERSITY

Reuters · 1d ago

Please log in to view news